Home › NCT05128006
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
Improving Dermatology Access by Direct-to-Patient Teledermatology and Computer-Assisted Diagnosis
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * New patient referrals to dermatology at San Francisco, Decatur, and Aurora from 2021-2025 Exclusion Criteria: * Patients who are not dermatology patients * Dermatology patients who are not seen at San Francisco, Decatur, and Aurora * Dermatology patients at San Francisco, Decatur, and Aurora who have visits only before 2021 or after 2025
About the study
This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.
What is being tested
- New patient teledermatology visit (other)
Sponsor: VA Office of Research and Development · Participants: 63,200 · Started: Nov 7, 2022
Contact the study team
- Dennis H Oh, MD PhD · Phone: (415) 750-2091
- Sara B Peracca, PhD MPH MS · Phone: (415) 221-4810
Official record on ClinicalTrials.gov — NCT05128006
Locations in the U.S.
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.